2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Authors
Keywords
-
Journal
EUROPACE
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-03-04
DOI
10.1093/europace/euab065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation
- (2021) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
- (2021) Tarun Dalia et al. Thrombosis Journal
- Restarting Oral Anticoagulation in Patients with Atrial Fibrillation After an Intracranial Hemorrhage
- (2020) Nhi Y. Nguyen et al. Cardiology in Review
- The interactions between anticonvulsants and non-vitamin K antagonist oral anticoagulant agents: a systematic review
- (2020) Mohamed Taha et al. EPILEPSY RESEARCH
- Rivaroxaban versus apixaban in non‐valvular atrial fibrillation patients with end‐stage renal disease or receiving dialysis
- (2020) Benjamin Miao et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study
- (2020) Pajaree Mongkhon et al. HEART RHYTHM
- Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis
- (2020) Toshiki Kuno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
- (2020) Stephan Windecker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation
- (2020) Tadataka Mizoguchi et al. STROKE
- Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage
- (2020) Matthew A Pappas et al. VASCULAR MEDICINE
- Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
- (2020) Paulus Kirchhof et al. Journal of the American Heart Association
- Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2020) Renato D. Lopes et al. JAMA Cardiology
- Acute thrombocytopenia after anticoagulation with rivaroxaban: A case report
- (2020) Xin-Yi He et al. World Journal of Clinical Cases
- Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease
- (2020) Matthew R. Weir et al. AMERICAN HEART JOURNAL
- Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients
- (2020) Stephen Y. Wang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial
- (2020) Yutao Guo et al. AMERICAN JOURNAL OF MEDICINE
- Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention
- (2020) Safi U. Khan et al. ANNALS OF INTERNAL MEDICINE
- Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage
- (2020) Guido J. Falcone et al. ANNALS OF NEUROLOGY
- Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
- (2020) John W. Stanifer et al. CIRCULATION
- Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention
- (2020) John H. Alexander et al. CIRCULATION
- Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
- (2020) So-Ryoung Lee et al.
- Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT‐AF / VTE study
- (2020) Paolo Colonna et al. CLINICAL CARDIOLOGY
- Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis
- (2020) Shinya Suzuki et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
- (2020) Sean D. Pokorney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
- (2020) Vincent J. Nijenhuis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events
- (2020) Santosh B. Murthy et al. STROKE
- Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry
- (2020) Irene Escudero-Martinez et al. BMJ Open
- Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
- (2020) Austin A. Robinson et al. JAMA Cardiology
- A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)
- (2020) Farhad Pazan et al. DRUGS & AGING
- Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
- (2020) Fabian Sanchis-Gomar et al. EUROPEAN HEART JOURNAL
- Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
- (2020) Yi-Hsin Chan et al. HEART RHYTHM
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2020) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
- (2020) Pavel Osmancik et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillation
- (2020) Souad Moudallel et al. PATIENT EDUCATION AND COUNSELING
- Clinically relevant interaction of rivaroxaban and valproic acid – A case report
- (2020) Lisa Langenbruch et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage
- (2020) Alessandro Biffi et al. STROKE
- Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
- (2020) Hee Tae Yu et al. Journal of the American Heart Association
- Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
- (2020) Chuan-Tsai Tsai et al. JAMA Network Open
- Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
- (2020) Phuong Pham et al. JAMA Network Open
- Outcomes associated with apixaban vs warfarin in patients with renal dysfunction
- (2020) Claudia Hanni et al. Blood Advances
- Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
- (2020) Joseph R. Shaw et al. Blood Advances
- Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
- (2020) Daehoon Kim et al. EUROPACE
- The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
- (2020) Jan Steffel EUROPEAN HEART JOURNAL SUPPLEMENTS
- Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review
- (2020) M. Farhan Nasser et al. HEART RHYTHM
- Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes
- (2020) Yi-Hsin Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
- (2020) Girish N. Nadkarni et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
- (2020) Ken Okumura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
- (2020) Giuseppe Boriani et al. THROMBOSIS AND HAEMOSTASIS
- Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis
- (2020) SungA Bae et al. HEART
- Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
- (2020) Helio P. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry
- (2019) Jean-Pierre Bassand et al. CIRCULATION
- Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
- (2019) Thomas Raphael Meinel et al. PLoS One
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
- (2019) Jonas Oldgren et al. EUROPEAN HEART JOURNAL
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Progress in the monitoring of direct oral anticoagulant therapy
- (2019) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus
- (2019) Marvin Kajy et al. AMERICAN JOURNAL OF THERAPEUTICS
- Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation
- (2019) Malini Madhavan et al. AMERICAN HEART JOURNAL
- Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
- (2019) David J. Seiffge et al. ANNALS OF NEUROLOGY
- Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
- (2019) Stefan H Hohnloser et al. EUROPEAN HEART JOURNAL
- Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
- (2019) Leif Friberg et al. EUROPEAN HEART JOURNAL
- The impact of nurse-led atrial fibrillation clinics on patient and healthcare outcomes: a systematic mixed studies review
- (2019) Kathy L Rush et al. European Journal of Cardiovascular Nursing
- Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial
- (2019) P. Moayyedi et al. GASTROENTEROLOGY
- Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy
- (2019) Leonardo Di Gennaro et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cerebral Ischemia in Patients on Direct Oral Anticoagulants
- (2019) Kosmas Macha et al. STROKE
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
- (2019) Peter Brønnum Nielsen et al. STROKE
- Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
- (2019) Géric Maura et al. BMJ Open
- Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
- (2019) Margarita Kushnir et al. Lancet Haematology
- Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
- (2019) Sylvia Haas et al. AMERICAN HEART JOURNAL
- Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation
- (2019) So-Ryoung Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
- (2019) Stefan H. Hohnloser et al. CIRCULATION
- Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature
- (2019) Victor M. Lu et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort
- (2019) Dongmin Kim et al. EUROPEAN HEART JOURNAL
- Timing use of novel anti-epileptic drugs: is earlier better?
- (2019) Stefano de Biase et al. Expert Review of Neurotherapeutics
- Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban
- (2019) Ifeoma Mary Eche et al. PHARMACOTHERAPY
- Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality
- (2019) Meng-Hsin Lin et al. STROKE
- Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation
- (2019) Hyun-Jung Lee et al. STROKE
- Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study
- (2019) Lucas Yixi Xing et al. THROMBOSIS RESEARCH
- Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
- (2019) Mette Søgaard et al. Journal of the American Heart Association
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
- (2019) Yuqing Deng et al. Journal of the American Heart Association
- Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke
- (2019) Ying Xian et al. JAMA Neurology
- Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
- (2019) Vasileios‐Arsenios Lioutas et al. Annals of Clinical and Translational Neurology
- Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
- (2019) Stephan Windecker et al. CIRCULATION
- Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug–drug interaction
- (2019) Tatjana Potpara et al. EUROPEAN HEART JOURNAL
- Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
- (2019) Tim J von Oertzen et al. EUROPEAN HEART JOURNAL
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
- (2019) Pascal Vranckx et al. LANCET
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
- (2019) Satoshi Yasuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor concordance among drug compendia for proposed interactions between enzyme‐inducing antiepileptic drugs and direct oral anticoagulants
- (2019) Emily K. Acton et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
- (2019) So-Ryoung Lee et al. STROKE
- Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program
- (2019) John Fanikos et al. THROMBOSIS AND HAEMOSTASIS
- Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
- (2019) Luis Alberto García Rodríguez et al. BMJ Open
- TV-based assistive integrated service to support European adults living with mild dementia or mild cognitive impairment (TV-AssistDem): study protocol for a multicentre randomized controlled trial
- (2019) Jessica Marian Goodman-Casanova et al. BMC Geriatrics
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
- (2019) James D. Douketis et al. JAMA Internal Medicine
- Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs
- (2019) Chun-Li Wang et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter
- (2019) Yankun Yang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
- (2019) Sachin J. Shah et al.
- Carotid Atherosclerosis in Patients with Atrial Fibrillation
- (2019) Zhaojia Wang et al. Current Atherosclerosis Reports
- Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials
- (2019) Tatjana S Potpara et al. EUROPACE
- Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
- (2019) Jennifer A. Frontera et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
- (2019) George D. Dangas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants
- (2019) Ilanit Zada et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children
- (2019) Leonardo R. Brandão et al. BLOOD
- Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation
- (2019) Tze-Fan Chao et al. CHEST
- Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis
- (2019) Aaqib H Malik et al. EUROPACE
- Delayed Intracranial Hemorrhage in Anticoagulated Geriatric Patients After Ground Level Falls
- (2019) Alexandra T. Cocca et al. JOURNAL OF EMERGENCY MEDICINE
- Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage
- (2019) So-Ryoung Lee et al. STROKE
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2019) William J. Powers et al. STROKE
- Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
- (2019) Christoph Male et al. Lancet Haematology
- Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants
- (2018) J. C. Purrucker et al. ACTA NEUROLOGICA SCANDINAVICA
- Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial
- (2018) Jean-Philippe Collet et al. AMERICAN HEART JOURNAL
- Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation
- (2018) Oh-Hyun Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Drug-induced thrombocytopenia after anticoagulation with rivaroxaban
- (2018) Marianne K. Pop et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
- (2018) Meena P. Rao et al. AMERICAN JOURNAL OF MEDICINE
- Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery
- (2018) Michelle M. Graham et al. ANNALS OF INTERNAL MEDICINE
- Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage
- (2018) Stefan T. Gerner et al. ANNALS OF NEUROLOGY
- Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
- (2018) Joseph H. Schafer et al. ANNALS OF PHARMACOTHERAPY
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
- (2018) Vittorio Pengo et al. BLOOD
- Safety and efficacy of non-vitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and meta-analysis
- (2018) Zhen Ge et al. Cardiovascular Therapeutics
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
- (2018) Tze-Fan Chao et al. CIRCULATION
- Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
- (2018) Deirdre A. Lane et al. CLINICAL CARDIOLOGY
- Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine
- (2018) Justin D. Lutz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
- (2018) Nikolaos Dagres et al. EUROPACE
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
- (2018) Jan Steffel et al. EUROPACE
- Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe
- (2018) Alexander C Fanaroff et al. EUROPEAN HEART JOURNAL
- Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
- (2018) Michael D Ezekowitz et al. EUROPEAN HEART JOURNAL
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- (2018) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119)
- (2018) L. Tittl et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays
- (2018) M. Jacquemin et al. International Journal of Laboratory Hematology
- Determinants of medication adherence in older people with dementia from the caregivers’ perspective
- (2018) Najwan El-Saifi et al. INTERNATIONAL PSYCHOGERIATRICS
- Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality
- (2018) Taku Inohara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia.
- (2018) Agnieszka Janion-Sadowska et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
- (2018) Wonkyung Byon et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Correlation of non-vitamin K antagonist oral anticoagulant exposure and cerebral microbleeds in Chinese patients with atrial fibrillation
- (2018) Yannie Soo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries
- (2018) Sara Garcia-Ptacek et al. Journal of the American Medical Directors Association
- Direct-acting oral anticoagulant drug level monitoring in clinical patient management
- (2018) Amihai Rottenstreich et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
- (2018) Olivier Varenne et al. LANCET
- Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study
- (2018) Marian Galovic et al. LANCET NEUROLOGY
- Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
- (2018) Duncan Wilson et al. LANCET NEUROLOGY
- Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin
- (2018) Ryota Kurogi et al. NEUROLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
- (2018) Jean-Pierre Bassand et al. PLoS One
- Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation
- (2018) Tae-Hoon Kim et al. STROKE
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
- (2018) Peter Gross et al. THROMBOSIS AND HAEMOSTASIS
- International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
- (2018) Robert Gosselin et al. THROMBOSIS AND HAEMOSTASIS
- The effect of bariatric surgery on direct-acting oral anticoagulant drug levels
- (2018) Amihai Rottenstreich et al. THROMBOSIS RESEARCH
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
- (2018) Kyu Kim et al. Korean Circulation Journal
- EdoxabaN Versus standard of care and theIr effectS on clinical outcomes in pAtients havinG undergonE Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE-TAVI AF trial
- (2018) Nicolas M. Van Mieghem et al. AMERICAN HEART JOURNAL
- Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation
- (2018) Adam D Niku et al. AMERICAN JOURNAL OF CARDIOLOGY
- Noncardioembolic Stroke in Patients with Atrial Fibrillation
- (2018) Vasiliki Katsi et al. ANGIOLOGY
- Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation
- (2018) Kazuhiko Kido et al. ANNALS OF PHARMACOTHERAPY
- Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment
- (2018) Giovanni Fazio et al. CLINICAL DRUG INVESTIGATION
- Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation
- (2018) Ramón Corbalán et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban in Asian Patients With Atrial Fibrillation
- (2018) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick
- (2018) Rupert Schreiner et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants
- (2018) Tomas Forslund et al. STROKE
- Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study
- (2018) Cecilia Becattini et al. THROMBOSIS AND HAEMOSTASIS
- Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
- (2018) Holger Reinecke et al. BMJ Open
- Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
- (2018) Christina L. Fanola et al. Journal of the American Heart Association
- The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation
- (2018) Rocco J. Cannistraro et al. Current Cardiology Reports
- 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
- (2018) Jason G. Andrade et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy
- (2018) Hyunjean Jung et al. CHEST
- Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
- (2018) Tze-Fan Chao et al. CIRCULATION
- Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
- (2018) Giuseppe Boriani et al. EUROPEAN HEART JOURNAL
- Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
- (2018) François-Xavier Mathy et al. EUROPEAN HEART JOURNAL
- Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Stroke prevention in AF: Of Asians and non-Asians
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
- (2018) Tze-Fan Chao et al. EUROPEAN HEART JOURNAL
- Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage
- (2018) Yi-Chun Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding
- (2018) Wayne A. Ray et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Left Atrial or Left Atrial Appendage Thrombus Resolution After Adjustment of Oral Anticoagulant Treatment
- (2018) Wei-Chieh Lee et al. Journal of Stroke & Cerebrovascular Diseases
- Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia
- (2018) Chun-Li Wang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
- (2018) David J Seiffge et al. LANCET NEUROLOGY
- Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
- (2018) Gregory Y.H. Lip et al. STROKE
- Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
- (2018) Alessandro Galgani et al. Frontiers in Neurology
- Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation
- (2017) Simon Hellwig et al. EUROPACE
- Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey
- (2017) Stefano Fumagalli et al. EUROPACE
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
- (2017) Hugh Calkins et al. EUROPACE
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
- (2017) Hugh Calkins et al. EUROPACE
- Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
- (2017) Anne Godier et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- 2017 ESC/EACTS Guidelines for the management of valvular heart disease
- (2017) Helmut Baumgartner et al. EUROPEAN HEART JOURNAL
- Atrial fibrillation as a risk factor for cognitive decline and dementia
- (2017) Archana Singh-Manoux et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
- (2017) Miguel Sousa-Uva* et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Effects of dabigatran according to age in atrial fibrillation
- (2017) Mandy N Lauw et al. HEART
- Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants
- (2017) Chan Soon Park et al. HEART RHYTHM
- Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran
- (2017) Chen-Hung Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
- (2017) Fernando Dominguez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
- (2017) Julia Seeger et al. JACC-Cardiovascular Interventions
- Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
- (2017) Shang-Hung Chang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the Direct Oral Anticoagulants on Activated Clotting Time
- (2017) Anne-Sophie Dincq et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients
- (2017) Bhradeev Sivasambu et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection
- (2017) David J. Greenblatt et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis
- (2017) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
- (2017) Giulia Renda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
- (2017) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2017) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape for Stroke Prevention in AF
- (2017) Menno V. Huisman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults
- (2017) Raymond B. Fohtung et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study
- (2017) Y. Song et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
- (2017) J. Douxfils et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
- (2017) Hakeam A. Hakeam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- (2017) Dirk Sibbing et al. LANCET
- Incidence and management of seizures after ischemic stroke
- (2017) Jeffrey Z. Wang et al. NEUROLOGY
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment
- (2017) Jaspreet Bhangu et al. PLoS One
- Incidence of seizures following initial ischemic stroke in a community-based cohort: The Framingham Heart Study
- (2017) Maria Stefanidou et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?
- (2017) Marco Proietti et al. STROKE
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study
- (2017) Anne G. Ording et al. Cancer Medicine
- Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
- (2017) Sang Joon An et al. Journal of Stroke
- Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation
- (2017) John W. Eikelboom et al. JAMA Cardiology
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
- (2016) Gregory Y.H. Lip et al. AMERICAN HEART JOURNAL
- Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
- (2016) Robert P. Giugliano et al. AMERICAN JOURNAL OF MEDICINE
- Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
- (2016) Clapton Dias et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression
- (2016) Carmelo Scarpignato et al. BMC Medicine
- Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine
- (2016) Dolly A. Parasrampuria et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers
- (2016) Lori A. Gordon et al. CIRCULATION
- Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective
- (2016) Michael D. Ezekowitz et al. CIRCULATION
- Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial HemorrhageCLINICAL PERSPECTIVE
- (2016) Tze-Fan Chao et al. CIRCULATION
- Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
- (2016) Ken Okumura et al. CLINICAL CARDIOLOGY
- Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults
- (2016) Yan Song et al. CLINICAL THERAPEUTICS
- Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs
- (2016) Claudia Stöllberger et al. EPILEPSY RESEARCH
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPACE
- The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
- (2016) Roopinder K. Sandhu et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
- (2016) Giulia Magnani et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
- (2016) Wayne A. Ray et al. GASTROENTEROLOGY
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease
- (2016) Peter A. Noseworthy et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?
- (2016) Ludovic Drouet et al. International Journal of Stroke
- The prognosis of acute symptomatic seizures after ischaemic stroke
- (2016) Thomas Leung et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes
- (2016) Benjamin A. Steinberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and risk of bleeding: the SMART study.
- (2016) S. K. Braekkan et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply
- (2016) A. Tripodi JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
- (2016) Allison E. Burnett et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage
- (2016) James M. Feeney et al. Journal of Trauma and Acute Care Surgery
- Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
- (2016) Jeff S Healey et al. LANCET
- Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery
- (2016) A. Marc Gillinov et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
- (2016) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation
- (2016) Tze-Fan Chao et al. STROKE
- Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
- (2016) T. Jared Bunch et al. Journal of the American Heart Association
- Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage
- (2016) James M. Feeney et al. Journal of Trauma and Acute Care Surgery
- Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation
- (2016) David J. Graham et al. JAMA Internal Medicine
- Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
- (2016) Gary Raskob et al. Lancet Haematology
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
- (2016) John H. Alexander et al. JAMA Cardiology
- Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality
- (2016) Jared W. Magnani et al. JAMA Cardiology
- The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
- (2016) Michelle Sholzberg et al. PLoS One
- Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
- (2015) Bernhard M. Kaess et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
- (2015) An S. De Vriese et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE
- (2015) Alvaro Avezum et al. CIRCULATION
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
- (2015) Yukihiro Koretsune et al. CIRCULATION JOURNAL
- The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
- (2015) Jeanne Mendell et al. CLINICAL DRUG INVESTIGATION
- Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
- (2015) Raffaele De Caterina et al. EUROPACE
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
- (2015) Andres Enriquez et al. EUROPACE
- Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
- (2015) Christian Sticherling et al. EUROPACE
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
- (2015) J. Steffel et al. EUROPEAN HEART JOURNAL
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
- (2015) Esther W. Chan et al. GASTROENTEROLOGY
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
- (2015) Luigi Di Biase et al. HEART RHYTHM
- Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation
- (2015) Li Hao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule
- (2015) Dolly A. Parasrampuria et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
- (2015) A. M. Shields et al. JOURNAL OF INTERNAL MEDICINE
- Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
- (2015) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
- (2015) Alessandro Di Minno et al. THROMBOSIS RESEARCH
- The pooled incidence of post-stroke seizure in 102 008 patients
- (2015) Safeng Zou et al. Topics in Stroke Rehabilitation
- Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
- (2015) Subodh Verma et al. BMC Surgery
- Monitoring and reversal of direct oral anticoagulants
- (2015) A. Cuker et al. Hematology-American Society of Hematology Education Program
- Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
- (2014) Shinya Goto et al. AMERICAN HEART JOURNAL
- Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
- (2014) D. Garcia et al. BLOOD
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2014) Matthew W. Sherwood et al. CIRCULATION
- Dementia and Cognitive Impairment
- (2014) Julie Hugo et al. CLINICS IN GERIATRIC MEDICINE
- Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
- (2014) S. Halvorsen et al. EUROPEAN HEART JOURNAL
- Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
- (2014) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
- (2014) Günter Breithardt et al. EUROPEAN HEART JOURNAL
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
- (2014) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. EUROPEAN HEART JOURNAL
- Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state
- (2014) Claudia Stöllberger et al. HEART & LUNG
- Acute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban
- (2014) Yohei Mima et al. INTERNAL MEDICINE
- Direct Oral Anticoagulants
- (2014) Jerrold H. Levy et al. JACC-Cardiovascular Interventions
- Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF
- (2014) I.G. Girgis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
- (2014) Anders Nissen Bonde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
- (2014) Adam Cuker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
- (2014) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient
- (2014) Apostolos Safouris et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
- (2014) M. Levi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aspirin in Patients Undergoing Noncardiac Surgery
- (2014) P.J. Devereaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Dosing Changes After Bariatric Surgery: Implications on the Mechanism for Altered Dose Requirements and Safety Concerns-An Alternative Viewpoint
- (2014) Lingtak-Neander Chan PHARMACOTHERAPY
- Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial
- (2014) Ka Sing Lawrence Wong et al. STROKE
- Vitamin K Antagonists and Risk of Subdural Hematoma
- (2014) Ben J. Connolly et al. STROKE
- Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
- (2014) Robert P. Giugliano et al. STROKE
- Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban
- (2014) Graeme J. Hankey et al. STROKE
- Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant
- (2014) Helen Mani et al. THERAPEUTIC DRUG MONITORING
- Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
- (2014) Takeshi Fuji et al. THROMBOSIS RESEARCH
- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. American Journal of Cardiovascular Drugs
- Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
- (2013) Olivier Hanon et al. Archives of Cardiovascular Diseases
- Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
- (2013) Vijay V. Upreti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
- (2013) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
- (2013) Ammar Majeed et al. CIRCULATION
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation
- (2013) Sean van Diepen et al. Circulation-Heart Failure
- Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation
- (2013) John J.V. McMurray et al. Circulation-Heart Failure
- Apixaban as an Alternate Oral Anticoagulant for the Management of Patients With Heparin-Induced Thrombocytopenia
- (2013) Jeanine M. Walenga et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-Analysis
- (2013) Salil V. Deo et al. JOURNAL OF CARDIAC SURGERY
- The Effects of the Antiplatelet Agents, Aspirin and Naproxen, on Pharmacokinetics and Pharmacodynamics of the Anticoagulant Edoxaban, a Direct Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects
- (2013) D Kubitza et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
- (2013) T. Baglin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Ischemic Stroke in an Obese Patient Receiving Dabigatran
- (2013) Lorenz Breuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric Bypass
- (2013) Peter Bechtel et al. OBESITY SURGERY
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines
- (2013) Hsin-Hui Tsai et al. PLoS One
- Preventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation
- (2013) Holger Reinecke et al. STROKE
- Dabigatran Versus Warfarin
- (2013) Masatsugu Hori et al. STROKE
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
- (2013) Christian Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Patient outcomes using the European label for dabigatran
- (2013) Andreas Clemens et al. THROMBOSIS AND HAEMOSTASIS
- Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure
- (2013) Kevin L. Thomas et al. Journal of the American Heart Association
- Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
- (2012) Joanne van Ryn et al. AMERICAN JOURNAL OF MEDICINE
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
- (2012) Harriette G.C. Van Spall et al. CIRCULATION
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
- (2012) Stephen Andrew LaHaye et al. EUROPEAN HEART JOURNAL
- Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis
- (2012) J. Steffel et al. EUROPEAN HEART JOURNAL
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation
- (2012) Hany S. Abed et al. HEART RHYTHM
- Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
- (2012) Yu-feng Hu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
- (2012) I. PRAGST et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of initial warfarin response in obese patients versus non-obese patients
- (2012) Jessica L. Wallace et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal
- (2012) Dar Dowlatshahi et al. STROKE
- Impact of dabigatran on a large panel of routine or specific coagulation assays
- (2012) Séverine Robert et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- The transport of antiepileptic drugs by P-glycoprotein
- (2011) Chunbo Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies
- (2011) K. Krauel et al. BLOOD
- Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach
- (2011) J. D. Douketis BLOOD
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism
- (2011) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Non-cardiac surgery in patients with coronary stents: the RECO study
- (2011) P. Albaladejo et al. HEART
- Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban
- (2011) Kenneth Todd Moore et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The effect of antiepileptic drugs on coagulation and bleeding in the perioperative period of epilepsy surgery: The Cleveland Clinic experience
- (2011) Crystal Manohar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence and predictors of acute symptomatic seizures after stroke
- (2011) E. Beghi et al. NEUROLOGY
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
- (2011) Hedi Schelleman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Early treatment after stroke for the prevention of late epileptic seizures: A report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis
- (2011) J.H. van Tuijl et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Left Atrial Catheter Ablation and Ischemic Stroke
- (2011) Karl Georg Haeusler et al. STROKE
- Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
- (2011) Ola Dahl et al. THROMBOSIS AND HAEMOSTASIS
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
- (2010) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Development and Validation of a Brief Performance-Based Fall Risk Assessment Tool for Use in Primary Care
- (2010) A. Tiedemann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Mexican Americans With Atrial Fibrillation Have More Recurrent Strokes Than Do Non-Hispanic Whites
- (2010) Jennifer R. Simpson et al. STROKE
- Assays for Measuring Rivaroxaban: Their Suitability and Limitations
- (2010) Edelgard Lindhoff-Last et al. THERAPEUTIC DRUG MONITORING
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin in patients with total knee arthroplasty
- (2010) Jiahao Huang et al. THROMBOSIS AND HAEMOSTASIS
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
- (2009) Hiroshi Watanabe et al. AMERICAN HEART JOURNAL
- Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study
- (2009) Alvaro Alonso et al. AMERICAN HEART JOURNAL
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure
- (2009) Dale C. Hesdorffer et al. EPILEPSIA
- Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
- (2009) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
- (2009) S. SCHULMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Stroke Secondary Prevention Services
- (2009) Joseph S. Ross et al. STROKE
- Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
- (2008) Stephan Rietbrock et al. AMERICAN HEART JOURNAL
- Rivaroxaban - an oral, direct Factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia
- (2008) Jeanine M. Walenga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
- (2008) H. Reinecke et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Resistance After Total Gastrectomy and Roux-en-Y Esophagojejunostomy
- (2008) Diana M Sobieraj et al. PHARMACOTHERAPY
- Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
- (2008) Albert Yuh-Jer Shen et al. STROKE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now